SCHEMBL4756770

SCHEMBL4756770

CC(=O)Oc1c(C(=O)Nc2nc(S(C)(=O)=O)cs2)ccc(C)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.45
NPC1 O15118 10/20 0.45
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 4/20 0.38
HPGD P15428 2/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RCE1 Q9Y256 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GCK P35557 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
PKM P14618 1/20 0.37
SORT1 Q99523 1/20 0.37
MAPT P10636 2/20 0.37
MITF O75030 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756354 0.87 RAB9A (0.50) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL10114229 0.87 USP2 (0.38) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL4756828 0.84 RAB9A (0.38) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL10114656 0.83 RAB9A (0.44) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL10114468 0.82 RAB9A (0.38) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL4756831 0.81 POLB (0.40) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL10114430 0.80 RAB9A (0.50) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL4757043 0.79 NPC1 (0.70) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL10114719 0.79 KDM4E (0.39) RAB9ANPC1ALDH1A1GAAMEN1
SCHEMBL703188 0.79 ALDH1A1 (0.50) RAB9ANPC1ALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885NPC1 585/4885ALDH1A1 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.